MEDTRONIC PLC

NYSE

MDT

=====TARGET PRICE $115-$118=======. Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The...

We have definitely risen above the upper resistance levels which have been in place since July of 2016. Short term price action uncertain. With RSI popping above 70, we are due for a short term correction. However, with the resistance broken, we may continue upward further and come back to test the new support in a few weeks.

With the market down today, MDT doesn't care... It's breaking tested, heavy resistance at all time highs. Technicals look great as well. *Check chart for more info*

We got a retracement of the fall at the opening of the day and the capital that has flown in seemes to have been speculative. It is leaving now ahead of the end of the day.

Good Morning, as we can see NYSE:MDT is in an uptrend and an ascending channel since December 2009, as long as this trend is not broken i would not worry and i will keep my position, the growth has been stable and it looks like a very solid company, the price it is above all its MA, i would only worry if the prices comes lower than USD80.

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable...

Last week may have been the shakeout before higher. Would give a little room on the downside but R/R looks good here for a long.

Everything is as usual, buy near uptrend. The company looks quite good, both from the point of view of fundamentals and technical analysis. I got in @ $88 and planning to hold this stock for the next 5 years or even more. In case of a reccesion or some other negative news, I'm looking to buy more @ $60-70.

- By insider Chairman & CEO of Medtronic Plc (MDT) Omar Ishrak bought 12,000 shares of MDT on 01/09/2019 at an average price of $84.05 a share. The total cost of this purchase was $1 million. I'm long from $82.61. Follow the $. Set stops.

MDT

L

$MDT has been reaching higher high after higher. today it finally had massive pullback. This the best time to get for the cheapest price for when earnings come.

Entry: 90.00 Stop: 83.50 Target: 110.00

Been monitoring $MDT for a breakout partially due to their Minimed 670g being such a leap in insulin pump tech. Strong sales and should dominate competition until their tech catches up. Entry at daily REBZ $89.72. Trends: Year 6 of 12 Week 4 of 9 Day 2 of 9 Quarterly needs 2 mo without touching the mode to confirm a 12 bar signal.

MDT: medtronic inc 2018-07-31 06:15:36 Detected possible FDA approval

Looking good, see if it breaks out. I think it will

$MDT possible C&H with bullish momentum closing candle

MDT: medtronic inc 2018-06-15 08:30:31 Detected possible FDA approval